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Abstract
1. Hexamethylenediisocyanate (HDI) is a widely used aliphatic diisocyanate and a well-
recognized cause of occupational asthma.
2. “Self” molecules (peptides/proteins) in the lower airways, susceptible to chemical 
reactivity with HDI, have been hypothesized to play a role in asthma pathogenesis 
and/or chemical metabolism, but remain poorly characterized.
3. This study employed unique approaches to identify and characterize “self” targets of 
HDI reactivity in the lower airways. Anesthetized rabbits free breathed through a 
tracheostomy tube connected to chambers containing either, O2, or O2 plus ~200 ppb 
HDI vapors. Following 60 minutes of exposure, the airways were lavaged and the fluid 
was analyzed by LC-MS and LC-MS/MS.
4. The low-molecular weight (<3 kDa) fraction of HDI exposed, but not control rabbit 
bronchoalveolar lavage (BAL) fluid identified 783.26 and 476.18 m/z [M+H]+ ions 
with high energy collision-induced dissociation (HCD) fragmentation patterns 
consistent with bis glutathione (GSH)-HDI and mono(GSH)-HDI. Proteomic analyses 
of the high molecular weight (>3 kDa) fraction of exposed rabbit BAL fluid identified 
HDI modification of specific lysines in uteroglobin (aka clara cell protein) and 
albumin.
5. In summary, this study utilized a unique approach to chemical vapor exposure in 
rabbits, to identify HDI reaction products with “self” molecules in the lower airways.
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Introduction
Diisocyanates are reactive chemicals with important uses in many different industries 
(Allport et al., 2003). Aliphatic diisocyanates are used to make elastomers and polyurethane 
coatings that help protect against corrosion, abrasion and damage from ultraviolet light 
(Ulrich, 1996). Global production of aliphatic diisocyanates exceeds 100 000 metric tonnes/
year (DOW, 2010), with usage in civilian, for example, autobody clear coat (Fent et al., 
2009; Pronk et al., 2007; Reeb-Whitaker et al., 2012; Sparer et al., 2004) and military 
sectors, for example, chemical agent-resistant coating (CARC) for aircraft, tanks, etc. 
(CARC 2000; Carlton & England, 2000; Kycia et al., 2012; LaPuma & Bolch, 1999; 
Wisnewski et al., 2012). Contemporary formulations generally consist of HDI oligomers 
with limited respirability (unless sprayed or heated) along with more volatile monomeric 
HDI and sometimes isophorone diisocyanate (IPDI) (Fent et al., 2009; Reeb-Whitaker et al., 
2012; Thomasen et al., 2011). Clinical studies suggest monomeric HDI, its oligomers and 
IPDI all can cause asthmatic responses (Clarke & Aldons, 1981; Vandenplas et al., 1993) 
and many advisory agencies such as the ACGIH®, the United States of America’s National 
Institute of Occupational Safety and Health, and the German Commission for the 
Investigation of Health Hazards of Chemical Compounds in the Work Area have 
recommended occupational exposure limits of 5 ppb as an 8-h time-weighted average and/or 
20 ppb for short time periods (German-MAK-HDI, 2002; GERMAN-MAK-IPDI, 2002; 
Rom & Markowitz, 2007). However, the Occupational Safety and Health Administration for 
the United States and equivalent agencies in many other countries, have not established, nor 
enforce, occupational exposure limits for aliphatic diisocyanates (OSHA, 2012; Rom & 
Markowitz, 2007).
Despite recognition of HDI’s ability to cause allergy/asthma, the mechanisms of disease 
pathogenesis remains unclear, hampering efforts at disease recognition, prevention and 
treatment (Redlich & Karol, 2002). Much uncertainty persists regarding the fate of HDI 
inhaled into the airways, and how it initiates airway pathology. One leading hypothesis is 
that HDI and other diisocyanates’ react with “self” molecules (e.g. peptides/proteins), 
altering their conformation and creating neo-epitopes or other signals that stimulate the 
immune system (Karol, 2001; Kennedy et al., 1989, 1994; Lange et al., 1999; Pauluhn et al., 
2006; Timchalk et al., 1994; Wisnewski et al., 2000). Albumin’s role as a reaction target for 
diisocyanate is suggested by serology demonstrating antibodies that bind diisocyanate-
conjugated albumin (but not other proteins) in exposed workers and the extraction of 
diamines (hydrolysis breakdown products of diisocyanates) from albumin in the peripheral 
circulation (Sabbioni et al., 2016; Sepai et al., 1995; Wisnewski et al., 2004). However, 
studies addressing the reactivity of diisocyanates with “self” molecules in the lower airways 
are ethically and logistically challenging to pursue in humans and have been limited to date 
(Redlich et al., 1997; Wisnewski et al., 2000).
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Animal studies of HDI exposure to identify “self” reaction targets in the lower airway have 
been compromised by inherent species differences with humans; for example, rodents are 
obligate nose breathers and their upper airways are proportionally larger and possess a 
scrubbing effect or capacity for absorbing/capturing reactive vapors (Ferguson et al., 1988; 
Harkema et al., 2006; Kennedy et al., 1993; Morris & Buckpitt, 2009; Schroeter et al., 
2013). Prior rat and guinea pig studies with several different radiolabeled monoand di-
isocyanates demonstrated limited penetration into the lower airways and higher levels of 
upper airway and oral absorption (Ferguson et al., 1988; Gledhill et al., 2005; Kennedy et 
al., 1994; Schroeter et al., 2013).
The present study explored a unique approach for delivering HDI vapor to the lower airways 
of an animal (bypassing the upper airways and esophagus) and subsequent identification of 
“self” reaction targets. The methodology was adapted from a previously published approach 
for maintaining spontaneous breathing in tracheotomized rabbits (Xia et al., 2011), and an 
older study (Marek et al., 1995) demonstrating the utility of oral intubation for delivering 
toluene diisocyanate (TDI) vapor to rabbit lower airways. In the present study, an 
endotracheal tube was inserted surgically, which provided a ready port for obtaining lower 
airway fluid (via lavage) immediately after exposure and obviated the notorious challenges 
of oral intubation in rabbits (Gografe et al., 2003). Although rabbits have been largely 
neglected as a model for diisocyanate asthma, they offer several advantages over smaller 
animal models for the present investigation, including larger amounts of airway fluid for LC-
MS/MS analyses and proteomics and greater homology of their albumin protein (a potential 
reaction target for HDI as described above) with humans (Wisnewski et al., 2000, 2004, 
2010). The findings of the present in vivo study are discussed in the context of prior in vitro 
and in vivo investigations and the potential mechanisms underlying diisocyanate asthma 
pathogenesis.
Materials and methods
Animals
Four male New Zealand White rabbits supplied by Charles River (Wilmington, MA) 
weighing 2.7–4.3 kg and free of common rabbit pathogens were acclimated in the Yale 
animal care facility for 1–2 weeks prior to the study. The day of the study, rabbits were 
fasted for 2–3 h, and then, anesthesia was induced by intramuscular (IM) injection of 
ketamine 30 mg/kg and xylazine 3 mg/kg. Subsequently, ears were sterilely prepared and 
venous catheters were inserted into each ear. The left ear venous port was used for 
continuous rate infusion of ketamine 25 mg/kg/h and xylazine 2.5 mg/kg/h (in 0.9% saline) 
via an intravenous fluid infusion pump (approximately 4 mL/kg/h). The right ear venous 
port was used to deliver euthanasia solution. Buprenorphine 0.05 mg/kg was administered 
IM, and 0.5% marcaine (up to 2 mg/kg bupivacaine) was injected as a local anesthetic, prior 
to placement of the endotracheal tube via tracheotomy. A 3.5 or 4mm (inner diameter) 
cuffed with murphy eye endotracheal tube (Henry Schein® Animal Health; Dublin, OH) was 
utilized and secured with skin sutures. Two control rabbits (C1 and C2) were allowed to 
spontaneously breathe through a tracheostomy tube connected to an exposure chamber filled 
with O2 (4 L/min). Two exposed rabbits (E1 and E2) spontaneously breathed through a 
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tracheostomy tube connected to an exposure chamber filled with O2 containing 147–252 ppb 
HDI vapor (4 L/min) generated by passive diffusion from a 14-cm diameter pyrex glass petri 
dish containing 15mL of HDI, as previously described (Wisnewski et al., 2004, 2013b). 
Puriss grade HDI (CAS Number: 822-06-0) solution from Sigma–Aldrich (St. Louis, MO) 
was ≥99% pure by gas chromatography, with a refractive index of n20/D 1.453, and a 
density of 1.047 g/mL at 20 °C. HDI vapor concentration was monitored with an Autostep 
toxic gas monitor (GMD Systems; Pittsburgh, PA) and validated using ISO-CHEK 
methodology (Galson Laboratories; East Syracuse, NY). The HDI and control exposures 
were performed inside a Hamilton® SafeAire® fume hood (Fisher Hamilton LLC; Two 
Rivers, WI). Following one hour of control (O2) or experimental (O2+HDI vapor) exposure, 
the airways were lavaged with 60mL of 0.9% saline and animals were euthanatized by 
intravenous administration of Euthasol® (Virbac AH Inc; Fortworth, TX). All studies were 
performed in accordance with approval from our Institutional Animal Care and Use 
Committee and our Environmental Health and Safety Office. The animal care program is 
fully accredited by the Association for Assessment and Accreditation of Laboratory Animal 
Care.
Processing of rabbit airway fluid
Airway fluid was centrifuged at 400 g for 10 min to pellet the cells and debris. The 
supernatant was collected and separated into <3 kDa and >3 kDa fractions using Amicon 
Ultra 0.5-mL Centrifugal Filters Ultracel 3K (UFC500324) obtained from Merck Millipore 
Ltd (Billerica, MA).
LC-MS analysis of rabbit airway fluid using an Agilent Q-TOF system
Ten milliliter of the low molecular weight (<3 kDa) fraction of rabbit airway fluids was 
acidified with 0.06% trifluoroacetic acid (TFA) from Sigma/Aldrich and concentrated via 
solid-phase extraction using Sep-Pak Vac C18 Cartridges (WAT054955) from Waters 
(Milford, MA). Sep-Pak Vac C18 cartridges were eluted with stepwise increasing 
concentrations of acetonitrile. Three 0.5mL fractions were collected following elution with 
20%, 60% and 100% acetonitrile. Each fraction was speedvacced to dryness, resuspended in 
HPLC/MS-grade water (Water Optima LC/MS-W6-4) from Fisher Scientific (Fairlawn, NJ) 
containing 0.1% formic acid from Sigma and subsequently analyzed on an Agilent G6550A 
Q-TOF system coupled to an Agilent 1290 Infinity LC system, using a rapid resolution HT 
Zorbax Eclipse Plus C18 column (2.1 × 50 mm, 1.8 µm), also from Agilent Technologies 
(Santa Clara, CA). Samples were mixed 1:1 in buffer A (water containing 0.1% formic acid) 
before loading and were eluted with 20% buffer B (acetonitrile containing 0.1% formic acid) 
over 2.5 min, increasing to 95% buffer B by 5 min and reverting back to 2% buffer B by 6 
min. Positive-ion electrospray was performed using the following parameters: gas temp 
− 280 °C, gas flow − 11 L/min, nebulizer-40 psig, sheath gas temp − 350 °C, sheath gas 
flow-11, Vcap-4000 V, nozzle voltage-2000 V, fragmentor voltage− 175 V, skimmer voltage 
65 V, octopole RF peak voltage 750 V, as previously described (Wisnewski et al., 2016). The 
data, acquisition range from 50 to 1700m/z, were acquired and analyzed using Mass Hunter 
Workstation software from Agilent.
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LC-MS/MS analysis of the <3 kDa fraction of rabbit airway fluid using a Thermo Scientific Q 
Exactive Plus
Concentrated fractions (<3 kDa) of airway lavage fluid that eluted from the Sep-Pak Vac 
C18 Cartridges with 20–60% acetonitrile were further analyzed by LC-MS/MS on a Thermo 
Scientific Q Exactive Plus (Waltham, MA) equipped with a Waters nanoAcquity UPLC 
system utilizing a binary solvent system (Buffer A: 100% water, 0.1% formic acid; Buffer B: 
100% acetonitrile, 0.1% formic acid). Trapping was performed at 5 µL/min, 97% Buffer A 
for 3 min using a Waters Symmetry® C18 180 µm × 20mm trap column. Peptides were 
separated using an ACQUITY UPLC PST (BEH) C18 nanoACQUITY Column 1.7 µm, 75 
µm × 250mm (37°C) and eluted at 330 nL/min with the following gradient: 3% buffer B at 
initial conditions; 5% B at 1 min; 35% B at 50 min; 50% B at 60 min; 90% B at 65 min; 
90% B at 70 min; return to initial conditions at 71 min. MS was acquired in profile mode 
over the 300–1700m/z range using 1 microscan, 70 000 resolution, AGC target of 3E6 and a 
maximum injection time of 45 ms. Data-dependent MS/MS were acquired in centroid mode 
on the top 20 precursors pre MS scan using 1 microscan, 17 500 resolution, AGC target of 
1E5, maximum injection time of 100 ms and an isolation window of 1.7 m/z. Precursors 
were fragmented by HCD activation with a collision energy of 28%. MS/MS were collected 
on species with an intensity threshold of 2E4, charge states 1–6 and peptide match off, with 
masses of interest (m/z=783.2653 and 476.1815) on an inclusion list. Dynamic exclusion 
was set to 20 s.
Sample preparation for LC-MS/MS analysis of >3 kDa fraction of airway fluid
HDI-modified proteins in BAL fluid were identified using proteomic approaches we 
previously described for human samples (Wisnewski et al., 2004, 2013b). Briefly, the >3 
kDa fraction of BAL fluid was concentrated 50-fold using a molecular weight cutoff spin 
column as described earlier, speedvacced to dryness and then dissolved in 10 µL 8 M urea, 
0.4 M ammonium bicarbonate. The proteins were reduced by the addition of 1.0 µL 45mM 
dithiothreitol (Thermo Fisher Scientific; Waltham, MA), incubated at 37°C for 20 min, 
alkylated with the addition of 1.0 µL 100mM iodoacetamide (Sigma-Aldrich, St. Louis, 
MO) and further incubated in the dark at room temperature for 20 min. The urea 
concentration was adjusted to 2M by the addition of 26–28 µL of water. Samples were then 
enzymatically digested with 0.2 µg of trypsin (Promega; Madison, WI) at 37°C for 16 h. 
Digested samples were desalted using C18 Ultra microspin columns (The Nest Group Inc; 
Southborough, MA) according to the manufacturer’s directions, with peptides eluted with 
0.1% TFA, 80% acetonitrile. Eluted sample was speedvacced dry, dissolved in MS-loading 
buffer (2% acetonitrile, 0.2% trifluoroacetic acid), and evaluated using a Nanodrop 2000 
UV-Vis Spectrophotometer (Thermo Scientific, Waltham, MA) to determine protein 
concentration based on A260/A280. Each sample was then further diluted with MS loading 
buffer to 0.04 µg/µL and 0.2 µg (5µL) was injected for LC-MS/MS analysis.
LC-MS/MS of >3 kDa fraction of airway fluid
LC-MS/MS analysis was performed on a Thermo Scientific Orbitrap Fusion equipped with a 
Waters nanoAcquity UPLC system utilizing a binary solvent system (Buffer A: 100% water, 
0.1% formic acid; Buffer B: 100% acetonitrile, 0.1% formic acid). Trapping was performed 
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at 5 µL/min, 97% Buffer A for 3 min using a Waters Symmetry® C18 180 µm × 20mm trap 
column. Peptides were separated using an ACQUITY UPLC PST (BEH) C18 
nanoACQUITY Column 1.7 µm, 75 µm × 250mm (37 °C) and eluted at 300 nL/min with the 
following gradient: 3% buffer B at initial conditions; 6% B at 5 min; 35% B at 155 min; 
85% B at 165 min; 85% B at 180 min; return to initial conditions at 181 min. MS was 
acquired from the Orbitrap in profile mode over the 350–1550 m/z range using quadrapole 
isolation, 1 microscan, 120 000 resolution, AGC target of 2E5, and a maximum injection 
time of 60 ms. MS/MS were collected in top speed mode with a 3-s cycle time on species 
with an intensity threshold of 5E4, charge states 2–8, peptide monoisotopic precursor 
selection preferred. Dynamic exclusion was set to 20 s. Data-dependent MS/MS were 
acquired in the Orbitrap in centroid mode using quadropole isolation, HCD activation with a 
collision energy of 28%, 1 microscan, 60 000 resolution, AGC target of 5E4, maximum 
injection time of 110 ms.
Identification of HDI-modified peptides
Proteomics data were analyzed using Proteome Discoverer (version 1.3) software (Thermo 
Fisher Scientific) and searched in-house using the Mascot algorithm (version 2.5.0) (Matrix 
Science; Boston, MA). The data were searched against a Uniprot database with taxonomy 
restricted to rabbit. Search parameters used were trypsin digestion with up to two missed 
cleavages; peptide mass tolerance of 10 ppm; MS/MS fragment tolerance of +0.25 Da; and 
variable modifications of methionine oxidation, carbamidomethylated cysteine and custom 
HDI modifications as previously described (Wisnewski et al., 2004, 2013b). Normal and 
decoy database searches were run with the confidence level set to 95% (p<0.05).
Results
Novel approach to study exposure to volatile chemicals
We adapted previously published methods for maintaining spontaneous breathing via 
endotracheostomy in anesthetized rabbits (Xia et al., 2011) to study lower airway exposure 
to the occupational allergen HDI. As depicted in Figure 1, rabbits were allowed to free-
breathe from a chamber filled with O2, or O2 containing HDI vapor for 60 minutes. Given 
the observed respiration rate (12–20 breaths per/minute) during the exposure period and the 
average rabbit tidal volume (10 mL/kg) (Garcia-Delgado et al., 2012), the total HDI vapor 
exposure dose was estimated to be ~30–50 µg. Immediately following exposure, the airways 
were lavaged through the endotracheal tube.
Identification of HDI reaction products with low (<3 kDa)-molecular-weight components of 
the airway fluid
The low-molecular-weight fraction of BAL fluid, from N=2 each HDI vapor and control 
exposed rabbits (E1, E2, C1 and C2, respectively), was concentrated by solid-phase 
extraction and eluted with stepwise increasing concentrations of acetonitrile. Samples were 
initially analyzed on an Agilent Q-TOF system as described in the methods. Total ion and 
base peak chromatograms (TICs and BPCs) from LC-MS analyses of paired BAL fluid 
samples from exposed versus unexposed rabbits were overall qualitatively similar 
(Supplemental materials, Figure S1). Extracted ion chromatograms (EICs) failed to provide 
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evidence for unreacted HDI or its hydrolysis product, hexamethylene diamine, for example, 
[M+H]+ ions with m/z’s of 169.09 or 117.14, respectively, in any of the <3 kDa BAL fluid 
fractions (data not shown). However, [M+H]+ ions with m/z’s (783.26 and 476.18) and 
retention times that matched in vitro HDI reaction products with GSH (Wisnewski et al., 
2013b), namely bis(GSH)-HDI and mono(GSH)-HDI respectively, were readily observed in 
BAL fluid fractions from each (N = 2) HDI exposed, but not control rabbits (Figure 2, and 
Supplemental materials Figures S2 and S3). Further, LC-MS/MS analyses of these selected 
[M+H]+ ions using a Q-Exactive-plus Orbitrap produced HCD fragments consistent with 
those previously published for bis(GSH)-HDI and mono(GSH)-HDI (Wisnewski et al., 
2013b), as shown in Figure 3 and further delineated in supplemental materials Figures S4 
and S5. For bis(GSH)-HDI, both the singly and doubly charged species were observed 
(Figure 3A, and Supplemental materials, Figure S2).
Identification of HDI reaction products with high molecular weight components of the 
airway fluid
We also analyzed the >3 kDa fraction of BAL fluid from HDI vapor-exposed rabbits using 
proteomic techniques to identify HDI-modified proteins and their sites of HDI conjugation. 
LC-MS/MS data identified one peptide with strong evidence of HDI modification in both 
exposed rabbits, E1 and E2 (Table 1, Figure 4 and Supplemental materials Figures S6–S8). 
This peptide comprises amino acids 63–70 of uteroglobin (aka Clara or club cell protein), 
with modification of the lysine at amino acid position 65 (K65) of the mature secreted 
protein, by partially hydrolyzed HDI (+142.11 kDa). The HDI-modified site is situated near 
uteroglobin’s C-terminus, in close proximity to a disulfide bond that bridges uteroglobin 
monomers. The side chain of uteroglobin K65 has been modeled to protrude from the surface 
(Bally & Delettre 1989), which may influence susceptibility to HDI conjugation, as shown 
in Figure 5. Two other sites of uteroglobin modification by HDI are suggested by the data, 
one in each of the two exposed rabbits, and include modification by partially hydrolyzed 
HDI (+142.11 kDa) and HDI cross-linking (+168.09 kDa) as shown in Table 1 and 
Supplemental materials Figures S6 and S7.
In addition to uteroglobin, the LC-MS/MS data provide strong evidence for HDI 
modification of albumin, on the lysine at amino acid position 525 (K525) of the mature 
secreted protein, in one of the exposed rabbits. Both the doubly and triply charged species of 
the tryptic peptide (spanning amino acids 525–534), modified by addition of partially 
hydrolyzed HDI, were observed (Table 1 and Supplemental materials, Figure S9). The same 
site has been identified as a dominate reaction site for human albumin with TDI vapor and 
methylene-diphenyl diisocyanate in vitro (Hettick & Siegel 2012; Hettick et al., 2012).
Discussion
This study pioneers a novel approach to investigate exposure to chemical vapors that cause 
asthma in the workplace, with a focus on the reaction of inhaled chemical with “self” 
molecules in the lower airways. To accomplish this goal, we adapted previously described 
methodology in which rabbits were anesthetized, tracheostomized and allowed to 
spontaneously free breathe (Xia et al., 2011) through an endotracheal tube. The use of an 
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endotracheal tube for delivering chemical vapors bypassed the scrubbing effect of the 
animals’ upper airways and provided a ready port for the collection of airway fluid (via 
lavage) immediately following exposure. Analysis of BAL fluid from HDI-exposed rabbits 
and comparison with unexposed control animals, using LC-MS and LC-MS/MS techniques, 
allowed identification of HDI reaction products with several different “self” molecules. The 
data confirm prior in vitro studies that demonstrate HDI vapor reactivity with GSH and 
albumin (Wisnewski et al., 2004, 2013b) and identify uteroglobin as another possible target 
for HDI modification in vivo.
Identification of GSH-HDI reaction products in vivo supports prior in vitro studies 
demonstrating HDI binding the reactive thiol of GSH under mixed phase (vapor/liquid) 
conditions, as exists at the air/fluid interface of the airways (Wisnewski et al., 2013b). GSH 
is a major anti-oxidant of the lower airways and S – GSH conjugation is an important step in 
the metabolism and excretion of many compounds (Cantin et al., 1987; Sipes et al., 1986). 
The process is usually enzyme (glutathione S-transferase) dependent; however, isocyanates 
may directly conjugate with GSH via a nucleophilic addition mechanism (Day et al., 1997; 
Ketterer, 1982; Reisser et al., 2002). GSH-HDI conjugates are cleaved by gamma glutamyl 
transpeptidase in vitro (Wisnewski et al., 2016), the first step in the mercapturic acid 
pathway, and GSH-monoisocyanates are excreted as their corresponding mercapturic acids 
in vivo (Slatter et al., 1991), suggesting a potentially protective role for GSH against HDI 
exposure.
The finding of HDI vapor conjugation to albumin in vivo supports the overwhelming 
number of studies demonstrating albumin’s importance as a carrier protein for HDI immune 
recognition, and the use of diisocyanate-albumin adducts as exposure biomarkers (Sabbioni 
et al., 2012; Wass & Belin, 1989; Wisnewski et al., 2004). Identification of K525 of albumin 
as a binding site for HDI in vivo is consistent with multiple in vitro studies identifying this 
site as a preferred diisocyanate target under dose-limiting conditions (Hettick & Siegel, 
2012; Hettick et al., 2012; Wisnewski et al., 2013b). The HDI-modified rabbit albumin 
tryptic peptide observed in vivo here is identical to the corresponding HDI-human albumin 
tryptic peptide observed in vitro (Wisnewski et al., 2013b), suggesting its potential as a 
biomarker for occupational exposure surveillance. The reason HDI-albumin reaction 
products were identified in only one of the two exposed rabbits is unclear, but may be related 
to the limited exposure time (one hour)/dose.
Uteroglobin as a reaction target for inhaled HDI vapor is a novel finding of the present study. 
Rabbit uteroglobin is the homolog of human secretoglobin family 1A member 1 
(SCGB1A1) and is commonly referred to by a variety of different names (Clara or club cell 
protein, CC10, CC16, blastokinin or polychlorinated biphenyl-binding protein) depending 
upon species/tissue source (Mantile et al., 1993; Mukherjee et al., 2007; Wolf et al., 1992). 
SCGB1A1 is relatively abundant in the airways, where it is secreted by nonciliated cells that 
specialize in chemical metabolism (Mukherjee et al., 2007). Polymorphism in human 
SCGB1A1 is associated with reduced levels of protein and increased likelihood of 
developing asthma (Candelaria et al., 2005; Ku et al., 2011; Laing et al., 2000; Taniguchi et 
al., 2013). Of particular relevance to the present study are findings (Kultz et al., 2015) 
demonstrating uteroglobin as a reaction target for naphthalene, a xenobiotic metabolically 
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activated within Clara cells. Kultz et al suggest chemical modification of proteins such as 
uteroglobin, which normally exhibit anti-inflammatory activity (Miele et al., 1987; 
Mukherjee et al., 2007; Ray et al., 2006; Shijubo et al., 2003; Vasanthakumar et al., 1988), 
may be key to the pathophysiology associated with certain xenobiotic exposures (Kultz et 
al., 2015). Further investigation, beyond the scope of this study, will be needed to determine 
if human uteroglobin is also susceptible to HDI modification in vivo, and if so, its potential 
relevance to occupational exposure and/or disease pathogenesis.
This study’s ready identification of GSH-HDI reaction, but limited HDI-protein reaction 
products warrants further discussion given the classical view of HDI (and other 
diisocyanates) as haptens that target proteins. The findings may be technical, related to the 
low total exposure dose, analytical methodology/detection limits, or the focus on BAL fluid 
versus proteins that are tissue-bound, phagocytized, exchanged with blood/lymph or 
otherwise removed from the air space. Alternatively, the data might indicate a more primary, 
and potentially complex role for GSH in response to exposure (Wisnewski et al., 2013a). 
Under normal conditions, airway fluid GSH levels are relatively high (~100 µM), while 
protein levels are low compared to tissue or blood levels (Bartlett et al., 2013; Cantin et al., 
1987; Grigg et al., 1996). Thus, GSH in airway fluid may compete with proteins for HDI 
reactivity, thereby preventing antigenic (or other pathogenic) consequences of protein 
modification. However, the thiocarbamate linkages of GSH with HDI (and other 
isocyanates) are reversible under the appropriate conditions (pH, temperature) and can 
mediate stable cabamylation (transfer of HDI) of specific functional groups of host proteins 
(Brown et al., 1987; Day et al., 1997; Wisnewski et al., 2013b). Thus, GSH reactivity with 
HDI may initially protect proteins and other vulnerable self-molecules of the airspace from 
chemical adduction (Brown et al., 1987; Wisnewski et al., 2005) but ultimately allow deeper 
tissue penetration of the chemical in a reversibly reactive form, possibly potentiating its 
pathogenicity (Wisnewski et al., 2013a, 2015).
The strengths and weaknesses of the present study should be recognized in interpreting the 
findings. The strengths include precise LC-MS/MS techniques and discovery science 
approaches to validate hypotheses based on prior in vitro findings and to identify previously 
unrecognized targets of HDI reactivity in vivo. Weaknesses include the study’s exploratory 
nature, assessing only N = 4 animals total and the experimental design, limited to short term 
exposures and bypassing possibly relevant interactions in the upper airways. The HDI 
exposure concentrations were relatively high to facilitate chemical detection (despite limited 
exposure duration) but were not unlike acute peak exposures, such as might occur during an 
accident or spill, which have been suggested as a crucial factor in the induction of 
diisocyanate-specific chemical respiratory allergy (Bernstein et al., 1993; Leroyer et al., 
1998). An additional weakness of the present study is the certainty of the structures 
proposed for the HDI reaction products (with GSH, albumin and uteroglobin) based 
exclusively on tandem LC-MS/MS. The sample size of the rabbit BAL fluid prevented 
purification and orthogonal verification by 1H- and 13C-NMR, as suggested by the American 
Chemical Society and Royal Society of Chemistry for defining new compounds (ACS, 2017; 
RSC, 2017). Finally, it should be noted the present study focused on monomeric HDI vapor 
and extension of the present findings to other industrially used diisocyanates remains to be 
tested.
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In summary, we developed an in vivo approach to evaluate the reaction products of the 
occupational allergen, HDI, with “self” molecules in the lower airway tract. The study 
involved vapor exposure of rabbits through a tracheostomy tube to overcome major 
limitations of previous animal studies, the scrubbing action of rodent upper airways and 
unintended delivery of chemical to the gastrointestinal tract. The findings confirm in vitro 
studies demonstrating the reactivity of HDI with GSH across a vapor-/liquid-phase boundary 
and suggest that GSH represents at least one portal of chemical entry into the lower 
respiratory tract. The data demonstrate in vivo HDI modification of albumin on K525, a site 
previously identified as a preferred target for diisocyanate conjugation through in vitro 
exposure dose titration studies (Hettick & Siegel 2012; Hettick et al., 2012). The data also 
identify a previously unrecognized target for HDI conjugation in the airways, namely 
uteroglobin, the rabbit homolog of human CC10/CC16, aka Clara or club cell protein 
(Mantile et al., 1993; Mukherjee et al., 2007). Thus, in vivo studies of rabbits exposed to 
HDI vapor via tracheostomy provide evidence that GSH, albumin and uteroglobin are “self” 
molecules susceptible to HDI modification upon inhalational exposure. The exposure model 
may be useful for investigating in vivo reaction targets of other chemical vapors inhaled 
from specific occupational or environmental settings.
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Figure 1. 
Schematic representation of experimental setup for in vivo HDI vapor exposure of rabbits. 
Anesthetized rabbits were allowed to spontaneously breathe through an endotracheal tube 
connected to a chamber filled with either O2 (control) or O2+HDI vapor generated by 
passive diffusion from an open petri dish containing liquid chemical. Endotracheostomy 
bypasses the scrubbing effect of the upper airways and provides a port for immediate 
collection of airway fluid (e.g. via lavage) following exposure.
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Figure 2. 
Extracted ion chromatograms for bis and mono(GSH)-HDI from rabbit airway lavage fluid. 
Concentrated fractions of BAL fluid from control (dashed lines) and HDI vapor-exposed 
rabbits (solid lines) were subjected to LC-MS using the Agilent system described in the 
methods, and EICs were generated for [M+H]+ ions with m/z’s previously defined for 
bis(GSH)-HDI (783.26) and mono(GSH)-HDI (476.18), as shown in Panels A and C, 
respectively. The defined ions exhibit retention times identical to bis(GSH)-HDI and 
mono(GSH)-HDI standards generated in vitro, Panels B and D, respectively.
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Figure 3. 
LC-MS and LC-MS/MS analyses of bis(GSH)-HDI and mono(GSH)-HDI from airway fluid 
of exposed rabbits. Panel A. Q-Exactive-plus Orbitrap analysis of concentrated BAL fluid 
from HDI-exposed rabbit, eluting off the LC column at 31.11 min. Singly and doubly 
charged ions with m/z’s matching bis(GSH)-HDI are highlighted with a red asterisk*. Panel 
B. Q-Exactive-plus Orbitrap MS/MS HCD fragmentation pattern of the 783.26 m/z [M+H]+ 
ion; consistent with that previously reported for bis(GSH)-HDI. Blue asterisks* correspond 
to expected HCD fragments of bis(GSH)-HDI as delineated in supplemental materials, 
Figure S4. Panel C. Q-Exactive-plus Orbitrap analysis of concentrated BAL fluid from HDI 
exposed rabbit eluting off LC column at 37.11 min. The [M+H]+ ion with the m/z (476.18) 
expected for mono(GSH)-HDI is highlighted with a red asterisk*. Panel D. Q-Exactive-plus 
Orbitrap MS/MS HCD fragmentation pattern of the 476.18 m/z [M+H]+ ion, consistent with 
that previously reported for mono(GSH)-HDI. Blue asterisks* correspond to expected HCD 
fragments of mono(GSH)-HDI, gray asterisks* correspond to GSH fragments, and the green 
asterisk* is consistent with the expected m/z for the [M+H]+ ion of partially hydrolyzed 
HDI, as delineated in supplemental materials, Figure S5.
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Figure 4. 
MS/MS analysis of HDI modified uteroglobin peptide. MS/MS HCD pattern for ion with 
m/z matching that of uteroglobin peptide modified by addition of partially hydrolyzed HDI 
(+142.1106 amu) on Lys65 of the mature protein (plus carbidomethylation of cysteine during 
sample preparation). Nine of the expected HCD fragment ions are highlighted in red (for 
additional information see supplemental materials, Figure S8).
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Figure 5. 
Molecular model highlighting site of HDI addition to rabbit uteroglobin. HDI modified 
Lys65 residues are highlighted yellow in the predicted molecular model of uteroglobin in its 
native state, dimerized by disulfide linkage in the C-terminus (Bally & Delettre, 1989).
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